Dr. Michael Mont, MD
Claim this profileNorthwell Health
Studies Musculoskeletal Disorder
Studies Osteoarthritis Treatment Costs
6 reported clinical trials
11 drugs studied
Area of expertise
1Musculoskeletal Disorder
Stage I
Stage II
2Osteoarthritis Treatment Costs
Affiliated Hospitals
Clinical Trials Michael Mont, MD is currently running
Polymotion Hip Resurfacing
for Hip Osteoarthritis
The goal of this clinical trial is to evaluate the safety and effectiveness of the Polymotion Hip Resurfacing (PHR) System compared to total hip arthroplasty, for adults who require hip resurfacing arthroplasty due to 1) non-inflammatory arthritis (degenerative joint disease) such as osteoarthritis, traumatic arthritis, or 2) mild dysplasia/developmental dislocation of the hip (DDH) up to Crowe Grade 1.
Recruiting1 award N/A10 criteria
Bone Marrow Aspirate
for Osteonecrosis
Osteonecrosis of the femoral head (ONFH) is a debilitating musculoskeletal disease that is characterized by localized death of bone cells and associated cellular elements within the subchondral bone. If it progresses, it results in the collapse of the femoral head (ball part of the hip) giving rise to secondary arthritis. This condition is associated with marked pain and loss of function, often necessitating a joint replacement. Due to the relatively young age of onset of ONFH (often in 20s and 30s), there is great interest in utilizing joint-preserving procedures prior to the need for joint replacement. Joint-preserving procedures include core decompression (CD) with and without bone grafts or cells, vascularized and non-vascularized bone grafting, as well as osteotomies. Inconsistent results for each of these procedures have been reported and there are no Clinical Practice Guidelines or medical community consensus opinions regarding the treatment of early-stage ONFH. The hypothesis to be tested is "Participants who have early-stage ONFH undergoing CD augmented with autogenous bone marrow aspirate concentrate will have better clinical and radiological outcomes than CD alone." This multi-center randomized controlled trial for early-stage ONFH is prospective and controlled for participant stage (only early-stage pre-collapse individuals) and surgical technique. Participants will be evaluated as per routine surgical follow-up, and at 6 months (telemedicine), 1- and 2- years using radiographs, MRIs, and questionnaires. This project will also explore the scientific basis for success vs. failure in individuals who have osteonecrosis, and have different demographics and bone marrow aspirate cell profiles.
Recruiting1 award N/A7 criteria
More about Michael Mont, MD
Clinical Trial Related5 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Michael Mont, MD has experience with
- Core Decompression
- Core Decompression Procedure With Autologous Bone Marrow Aspirate Concentrate
- Trident II Tritanium Acetabular Shell
- Enteric Coated Aspirin
- Rivaroxaban
- Warfarin
Breakdown of trials Michael Mont, MD has run
Musculoskeletal Disorder
Osteoarthritis Treatment Costs
Osteoarthritis
Perthes Disease
Bone Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael Mont, MD specialize in?
Michael Mont, MD focuses on Musculoskeletal Disorder and Osteoarthritis Treatment Costs. In particular, much of their work with Musculoskeletal Disorder has involved Stage I patients, or patients who are Stage II.
Is Michael Mont, MD currently recruiting for clinical trials?
Yes, Michael Mont, MD is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Michael Mont, MD has studied deeply?
Yes, Michael Mont, MD has studied treatments such as Core Decompression, Core Decompression Procedure with Autologous Bone Marrow Aspirate Concentrate, Trident II Tritanium Acetabular Shell.
What is the best way to schedule an appointment with Michael Mont, MD?
Apply for one of the trials that Michael Mont, MD is conducting.
What is the office address of Michael Mont, MD?
The office of Michael Mont, MD is located at: Northwell Health, New York, New York 10075 United States. This is the address for their practice at the Northwell Health.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.